// App-Quantinova.ai

3917 : Breast cancer cells expose thymidine kinase 1 as a new immunotherapy target

Researchers

Presenter

  • Evita G. Weagel

Principal Investigators

  • Rachel A. Brog

  • Michelle H. Townsend

  • Edwin J. Velazquez

  • Toshiko A. Becker

  • Camilo A. Mejia

  • Michael R. Downey

  • Juan A. Arroyo

  • Richard A. Robison

  • Kim L. ONeill

Medical Centers

  • Brigham Young University, Provo, UT

  • Utah Valley Regional Medical Center Laboratory, Provo, UT.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Dialkylphosphate

Drug/Treatment

  • MD 1003

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved